Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Susan E. Prockop, MD, Aisha Hasan, MD, Guenther Koehne, MD PhD, Ekaterina Doubrovina, MD PhD, Craig S. Sauter, MD, Juliet N, Barker, MBBS, Karim Baroudy, Farid Boulad, MD, Sergio Giralt, MD, Ramzi Khalaf, Nancy A. Kernan, MD, Esperanza B Papadopoulos, MD, Doris M. Ponce, MD, Andromachi Scaradavou, MD, Stephanie Suser, Gloria Wasilewski, RN, Richard J. O'Reilly, MD

Blood (2014) 124 (21): 184.

https://doi.org/10.1182/blood.V124.21.184.184

Published: 2014

Journal Articles

Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Malignancies in Immunodeficient Recipients

Susan E. Prockop, MD, Ekaterina Doubrovina, MD, PhD, Juliet N Barker, MBBS, Karim Baroudy, Farid Boulad, MD, Ramzi Khalaf, Nancy A. Kernan, MD, Rachel Kobos, MD, Esperanza B. Papadopoulos, MD, Andromachi Scaradavou, MD, Trudy N Small, MD, Gloria Wasilewski, RN, Richard J. O'Reilly, MD

Blood (2012) 120 (21): 577.

https://doi.org/10.1182/blood.V120.21.577.577

Published: 2012

Journal Articles

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation

Blood (2012) 119 (11): 2644–2656.

https://doi.org/10.1182/blood-2011-08-371971

Published: 2012

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Treatment Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia (tMDS/AML)

Rachel Kobos, MD, Peter G Steinherz, MD, Nancy A Kernan, MD, Susan E Prockop, MD, Andromachi Scaradavou, MD, Trudy N Small, MD, Neerav Shukla, MD, Ramzi Khalaf, Richard J. O'Reilly, MD, Farid Boulad, MD

Blood (2010) 116 (21): 2363.

https://doi.org/10.1182/blood.V116.21.2363.2363

Published: 2010

Journal Articles

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Susan Prockop, MD, Ekaterina Doubrovina, MD, PhD, Farid Boulad, MD, Nancy A Kernan, MD, Rachel Kobos, MD, Andromachi Scaradavou, Trudy N Small, M.D, Ramzi Khalaf, Juliet Barker, MBBS, (Hons), FRACP, Guenther Koehne, MD, Esperanza Papadopoulos, MD, James W. Young, MD, Richard J. O'Reilly, MD

Blood (2010) 116 (21): 487.

https://doi.org/10.1182/blood.V116.21.487.487

Published: 2010

NARROW

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Malignancies in Immunodeficient Recipients

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Treatment Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia (tMDS/AML)

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Email alerts

ASH Publications

American Society of Hematology

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Malignancies in Immunodeficient Recipients

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric Patients with Treatment Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia (tMDS/AML)

Adoptive Immune Cell Therapy Using Third Party T-Cell Donors In the Treatment of EBV Related Diseases In Immunodeficient Recipients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only